Bernstein analyst Lee Hambright raised the firm’s price target on Stryker (SYK) to $450 from $440 and keeps an Outperform rating on the shares. The firm cites a strong Q1, as revenue of $5.9B grew 10.1% organic and beat consensus by 3%. Performance was healthy across regions and segments.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker’s Strong Performance and Growth Potential Justify Buy Rating
- Stryker Corp’s Earnings Call Highlights Robust Growth
- Stryker price target raised to $456 from $405 at Roth Capital
- Stryker’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Stryker’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating